Burkhart Erin — SEC insider filings

SEC reporting owner CIK 1927648. 14 insider filings on record with FilingPulse; latest filed 2026-09-23.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2022-05-18 to 2026-09-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOMARIN PHARMACEUTICAL INC (BMRN)GVP, Chief Accounting Officer11—5 legs · 7,425 sh · $560,44913
GILEAD SCIENCES, INC. (GILD)SVP, Controllership3——6

Insider filings — Burkhart Erin

FiledFormIssuerReported transactionsSource
2026-09-234GILEAD SCIENCES, INC. (GILD)Option exercise (M): 2,223 · Tax withholding (F): 768 @ $152.67 · Option exercise (M): 2,223 (derivative)EDGAR
2026-03-124GILEAD SCIENCES, INC. (GILD)Grant/award (A): 2,355 (derivative) · Grant/award (A): 5,455 (derivative) @ $0EDGAR
2025-09-234GILEAD SCIENCES, INC. (GILD)Grant/award (A): 8,890 (derivative)EDGAR
2025-05-204BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 996 @ $59.27 · Sale (S): 1,786 @ $59.31EDGAR
2025-03-204BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 1,295 @ $71.52EDGAR
2025-03-184BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 823 @ $69.44 · Grant/award (A): 5,970 @ $0 · Grant/award (A): 9,230 (derivative) @ $0EDGAR
2025-02-254BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 1,344 @ $68.38EDGAR
2024-08-154BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 714 @ $90EDGAR
2024-05-204BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 993 @ $76.97EDGAR
2024-04-124BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 2,286 @ $90EDGAR
2024-03-194BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 4,720 @ $0 · Tax withholding (F): 372 @ $83.87 · Grant/award (A): 7,050 (derivative) @ $0EDGAR
2023-05-184BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 796 @ $92.02EDGAR
2023-03-174BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 3,760 @ $0 · Grant/award (A): 5,720 (derivative) @ $0EDGAR
2022-05-184BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 11,130 @ $0 · Grant/award (A): 17,490 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1927648 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs